AstraZeneca stock gains 2.18 percent after-hours to EUR 143.95
Published on 10/07/2026 at 18:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AstraZeneca stock gained 2.18 percent after-hours to EUR 143.95 at 6:02 p.m. CEST on October 7, 2026, according to Lang & Schwarz. The percentage change is measured against the prior close at Lang & Schwarz.
After-hours trading
The previous Lang & Schwarz close was EUR 140.88. The bid was EUR 143.75 and the ask was EUR 144.15. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Recent company context
On October 5, AstraZeneca announced that it had completed a $2 billion equity investment in Summit Therapeutics to accelerate development of ivonescimab, a bispecific antibody targeting PD-1 and VEGF, in combination with antibody-drug conjugates across tumor types, according to AstraZeneca. The company describes itself as a science-led biopharmaceutical business focused on oncology, rare disease and biopharmaceuticals, with medicines sold in more than 125 countries.
